Filing Flows

Filing Flows › Apnimed (APMD) › Next earnings date

Apnimed (APMD) earnings on Nov 11, 2026: what to expect

Apnimed (APMD) is expected to report earnings on Nov 11, 2026 (estimated), in 3 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.60 (−$0.61 to −$0.59, 2 estimates). It beat the EPS estimate in 0% of the quarters on record; Filing Flows' model gives it a 60% chance of beating next time.

Report dateNov 11, 2026 (estimated)
Days to go3
EPS estimate−$0.60
Beat rate0%

What to watch

Last quarter (Q2 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:

Apnimed: revenue lines, growth year over year, Q2 2026Apnimed: revenue lines, growth year over year, Q2 2026Revenue-29%

The last report

Apnimed reported revenue of $12.1M for the second quarter 2026 (-29% Y/Y), net earnings $126M. How it makes money → · Every quarter →

Apnimed's latest quarter

Apnimed, Q2 2026: revenue $12.1M (-29% year over year), operating margin -96.9%, net earnings $126M. The chart follows the revenue to costs, profit and cash.

Questions

When does APMD report earnings?

Apnimed is expected to report on Nov 11, 2026 (estimated).

What are analysts expecting from Apnimed?

EPS of −$0.60 for the quarter.

Does Apnimed usually beat earnings?

It beat the consensus EPS estimate in 0% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.